Clinical Trials Browser

INDUSTRY × FANG vaccine × Clear all

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05807035 2025-09-17

Autologous Tumour Vaccine Trial

Phase 1 Recruiting

30 enrolled

Tumor-Agnostic

Neoplasms

NCT03842865 2025-06-05

Expanded Access of Vigil in Solid Tumors

Temporarily not available

GynecologicSarcoma

Uterine Cervical Neoplasms, Ovarian Neoplasms, Sarcoma, Ewing, Uterine Neoplasms

NCT03495921 2023-04-26

VITA

Phase 3 Terminated

32 enrolled 13 charts

Sarcoma

Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, Sarcoma, Sarcoma, Ewing, Neoplasms, Connective and Soft Tissue, Neoplasms, Bone Tissue, Neuroectodermal Tumors, Primitive, Peripheral, Rare Diseases

NCT03073525 2023-04-05

A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers

Phase 2 Completed

25 enrolled 15 charts

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT02511132 2022-12-22

A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma

Phase 2 Completed

22 enrolled 13 charts

Sarcoma

Sarcoma, Sarcoma, Ewing

NCT01061840 2022-03-15

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

Phase 1 Completed

100 enrolled

GastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Sarcoma, Ewing

NCT02574533 2017-09-27

Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma

Phase 1 Completed

2 enrolled

Dermatologic

Melanoma

NCT02639234 2017-07-31

Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003715 2015-12-03

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

Phase 2 Terminated

425 enrolled